Patient- and medication-related information -Anticoagulation plan (continue/hold/restart) -Key medications and peri-/post-op adjustments -Relevant medical conditions -Pre-op parameters to be optimized In addition to the information listed above, its also recommended to include a closing statement requesting medical clearance with the overall risk assessment
Semaglutide, marketed as Ozempic for diabetes and Wegovy for weight management, represented the gold standard for single-receptor GLP-1 therapy
Still no cagrilintide
Patients should wear loose, breathable clothing, avoid hot baths or showers that may exacerbate itching, and use fragrance-free, hypoallergenic skincare products
Your provider can adjust your diabetes management plan, initiate B12 supplementation if needed, or consider alternative medications if metformin is contributing to symptoms
2024;7(1):e23500502350050